🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Really pleased to share the final program ➡️ Focus meets UK, Toulouse. October 12-13th ☀️ President : Prof Ananya💙 @achoud72.bsky.social Morgan Roupret 🌟🌟🌟🌟🌟🌟🌟🌟🌟🌟🌟 . @FOCUS_meeting Ploussard Guillaume Jb Beauval Pignot Géraldine Pouessel Damien Roubaud Guilhem @MRoumiguie

TP vs TR in csPCa Detection. No definitive proof of superiority of TP MRI-TB over TR approach, advantage for anterior/apex location but no large RCT. Looking forward to #PERFECT trial results. ⁦Morgan Roupret⁩ ⁦European Urology Oncology⁩ sciencedirect.com/science/articl…

Surgery with or Without Darolutamide in High-risk and/or Locally Advanced Prostate Cancer: The SUGAR Phase 2 Trial: ✅MRI-based definition of high risk ✅ADT-sparing ✅novel exploratory endpoint (non-curable PFS) ⁦⁦Morgan Roupret⁩ ⁦Association Française d'Urologie - AFU⁩ sciencedirect.com/science/articl…

See you tonight... And tomorrow for Focus, 5th edition 🇬🇧🇫🇷 Alberto Bossi Laurence Albiges Eric Barret Karim Bensalah Pierre Blanchard, MD Prof Ananya💙 @achoud72.bsky.social Helissey carole Nick James also on @Prof-Nick-James.bsky.social Jonathan Khalifa 🎗️ Prof Param Mariappan FRCS(Urol), PhD Arnaud Méjean, MD, PhD Vedang Murthy Piet Ost Tom Powles Morgan Roupret Thomas Zilli Marc-Olivier Timsit, MD, PhD 🎗️

⁦Alberto Martini⁩ on stage and back to Toulouse for ⁦@FOCUS_meeting⁩. Great talk on intermediate endpoint in prostate cancer

Listening to "December 2023 – Eur Urol Oncology highlights" at buzzsprout.com/2220728/142769… European Urology Oncology European Association of Urology (EAU) Ashish M. Kamat, MD, MBBS Riccardo Campi Cathy Elena Castro Alicia Morgans, MD, MPH Ploussard Guillaume Jeremy Teoh Laurence Albiges Declan Murphy

Check our study on the prediction of EPE for selecting men for nerve sparing (full/incremental/none) on Prostate Cancer and Prostatic Diseases as part of the Emerging Leaders series nature.com/collections/fc… pubmed.ncbi.nlm.nih.gov/38182804/ Special thanks to friend and mentor Ploussard Guillaume

Nous vous souhaitons une année pleine d’innovations et de nouveautés scientifiques ! Et vous remercions de votre confiance. RDV les 10 et 11 octobre pour #FOCUS2024meetsCanada ! Jb Beauval Pignot Géraldine Ploussard Guillaume Pouessel Damien @MRoumiguie Roubaud Guilhem Paul Sargos #urology #oncology

Take 5 minutes and participate to our online survey on PCa screening and management in BPH patients candidates for enucleation -How do you screen patients? -How do you manage incidental PCa? Ploussard Guillaume Benjamin Pradere Cosimo De Nunzio Vincent Ⓜ️israi Jean-Nicolas Cornu docs.google.com/forms/d/e/1FAI…

🔥 The added-value of side-specific systematic bx in patients diagnosed by #MRI-targeted bx European Urology Oncology 🇪🇺 Huge congratulations to the remarkable European team and my fellow researchers for their relentless efforts! Institut Jules Bordet Instituut Société Belge d'Urologie European Association of Urology (EAU) linkinghub.elsevier.com/retrieve/pii/S…

Autre membre du comité organisateur @FOCUS_meeting Pouessel Damien, oncologue médical à l'IUCT Oncopole – Institut Claudius Régaud #Toulouse Focus 2024 meets Canada : 10 et 11/10/2024 #Toulouse Jb Beauval Pignot Géraldine Ploussard Guillaume @MRoumiguie Roubaud Guilhem Paul Sargos

Transperineal Versus Transrectal Magnetic Resonance Imaging–targeted Biopsies: Results of PERFECT trial (CCAFU-PR1) ⁦Morgan Roupret⁩ ⁦Eric Barret⁩ ⁦@GaelleFiard⁩ ⁦Jb Beauval⁩ ⁦Salin Ambroise⁩ ⁦European Urology Oncology⁩ ⁦Association Française d'Urologie - AFU⁩ sciencedirect.com/science/articl…

Congrats to our Feb IMPACT Award winners Marcin Miszczyk & Pawel Rajwa! Their manuscript "Efficacy of metastasis-directed therapy in PCa" was the most influential work featured in our Feb 2024 issue! Full Article: buff.ly/4bzxGgU Spotlight: buff.ly/3ToeUCd

Great honor to receive IMPACT Award European Urology with Marcin Miszczyk 🇵🇱🇵🇱 🇵🇱. Congrats to the entire team Shahrokh F. Shariat Ploussard Guillaume Quoc-Dien Trinh, MD, MBA Thomas Zilli Piet Ost Roderick van den Bergh Juan Gómez Rivas Giorgio Gandaglia Benjamin Pradere Ekaterina Laukhtina Takafumi Yanagisawa

Reassuring data: very low risk of grade inflation/overtreatment induced by MRI-targeting. Congrats Michael and thanks to all co-authors for this collaborative work Romain Diamand @GaelleFiard Thierry Roumeguere sciencedirect.com/science/articl…

🗣 Et en attendant le programme complet de FOCUS 2024 meets Canada, retrouvez les orateurs et participants de l'édition 2023 qui vous parlent de #focusmeeting Jb Beauval Pignot Géraldine Ploussard Guillaume Pouessel Damien @MRoumiguie Roubaud Guilhem Paul Sargos

A heartfelt thank you to the entire UROSUD team #Toulouse for this invaluable experience. Six months of intensive surgery and new friends. A special gratitude to Benjamin Pradere Ploussard Guillaume Christophe ALMERAS Salin Ambroise Jb Beauval for their unwavering support and mentorship

Buongiorno da @oltredna 🇮🇹 - 🧵 Il nostro obiettivo è la prevenzione e la diagnosi precoce grazie alla medicina personalizzata. Contribuiamo ad un futuro nel quale la diagnosi precoce e la personalizzazione delle cure siano realtà.

2years of ADT after radical prostatectomy for high Risk #prostate #cancer patients did not improve MFS in phase III RCT AFU-GETUG 20 trial. #GU25 Need to identify better biomarkers of relapse Association Française d'Urologie - AFU GETUG Pr. Alexandre de La Taille Morgan Roupret Ploussard Guillaume

💻 Résumé de l'ASCO GU : Rejoignez-nous nombreux ce soir à 19h30 pour décrypter ensemble les résultats qui façonneront notre pratique clinique ! Morgan Roupret Bigot Pierre Ploussard Guillaume Partenaire : Astellas Pharma Lien de connexion : frequencemedicale.com/index.php?op=a… #GU25 #ASCOGU25